Salmonella typhimurium infection increases p53 acetylation in intestinal epithelial cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 298, Issue 5, 2010, Pages

  Wu, Shaoping ^a   Ye, Zhongde ^a   Liu, Xingyin ^a   Zhao, Yun ^a   Xia, Yinglin ^b   Steiner, Andrew ^a   Petrof, Elaine O ^c   Claud, Erika C ^d   Sun, Jun ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Acetylation; Bacteria; Effector; Inflammation; TTSS; Ubiquitination

Indexed keywords

ACYLTRANSFERASE; BACTERIAL PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; VIRULENCE FACTOR;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CELL CYCLE ARREST; CELL FREE SYSTEM; CONTROLLED STUDY; EMBRYO; ENTERITIS; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ACETYLATION; ANIMALS; BACTERIAL PROTEINS; CELL CYCLE; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HELA CELLS; HUMANS; INTESTINAL MUCOSA; MICE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77951451986     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00526.2009     Document Type: Article

References (49)

1. Asfaha S, MacNaughton WK, Appleyard CB, Chadee K, Wallace JL. Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 281: G635-G644, 2001.
2. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H, Hardt WD. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858, 2003.
3. Ben-Barak Z, Streckel W, Yaron S, Cohen S, Prager R, Tschape H. The expression of the virulence-associated effector protein gene avrA is dependent on a Salmonella enterica-specific regulatory function. Int J Med Microbiol 296: 25-38, 2006.
4. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, McNally E, Pickart C, Ma A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5: 1052-1060, 2004.
5. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, Chen H, Madara JL, Orth K, Neish AS. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 169: 2846-2850, 2002.
6. De la Cruz-Hernandez E, Perez-Cardenas E, Contreras-Paredes A, Cantu D, Mohar A, Lizano M, Duenas-Gonzalez A. The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study. Virol J 4: 18, 2007.
7. Du F, Galan JE. Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog 5: e1000595, 2009.
8. Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, Sun J. β-Catenin activity negatively regulates bacteria-induced inflammation. Lab Invest 87: 613-624, 2007.
9. Grone HJ, Weber K, Helmchen U, Osborn M. Villin - a marker of brush border differentiation and cellular origin in human renal cell carcinoma. Am J Pathol 124: 294-302, 1986.
10. Hardt WD, Galan JE. A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc Natl Acad Sci USA 94: 9887-9892, 1997.
11. 1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
12. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400, 1995.
13. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908, 2005.
14. Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, Turer EE, Lee BL, Shiffin N, Advincula R, Malynn BA, Werts C, Ma A. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28: 381-390, 2008.
15. Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Sakata H, Matsushita K, Komatsu A, Brooks R, Ochiai T. Role of histone deacetylase inhibitor in adenovirus-mediated p53 gene therapy in esophageal cancer. Anticancer Res 28: 665-671, 2008.
16. Hsu CH, Chang MD, Tai KY, Yang YT, Wang PS, Chen CJ, Wang YH, Lee SC, Wu CW, Juan LJ. HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J 23: 2269-2280, 2004.
17. Hsu Y, Jubelin G, Taieb F, Nougayrede JP, Oswald E, Stebbins CE. Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J Mol Biol 384: 465-477, 2008.
18. Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS. Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3: 233-244, 2008. (Pubitemid 351494717)
19. Kruse JP, Gu W. SnapShot: p53 posttranslational modifications. Cell 133: 930-930.e1, 2008.
20. Lane DP. Cancer. p53, guardian of the genome. Nature 358: 15-16, 1992.
21. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
22. Liao AP, Petrof EO, Kuppireddi S, Zhao Y, Xia Y, Claud EC, Sun J. Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PLoS ONE 3: e2369, 2008.
23. Liu X, Lu R, Wu S, Sun J. Salmonella regulation of intestinal stem cells through the Wnt/beta-catenin pathway. FEBS Lett 584: 911-916, 2010.
24. Liu Y, Bodmer WF. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci USA 103: 976-981, 2006. (Pubitemid 43212207)
25. Logunov DY, Scheblyakov DV, Zubkova OV, Shmarov MM, Rakovskaya IV, Gurova KV, Tararova ND, Burdelya LG, Naroditsky BS, Ginzburg AL, Gudkov AV. Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene 27: 4521-4531, 2008.
26. Mauser A, Saito S, Appella E, Anderson CW, Seaman WT, Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol 76: 12503-12512, 2002. (Pubitemid 35386936)
27. McCormick BA, Colgan SP, Delp-Archer C, Miller SI, Madara JL. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol 123: 895-907, 1993. (Pubitemid 23333578)
28. Melino G, De Laurenzi V, Vousden KH. p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2: 605-615, 2002.
29. Miller SI, Mekalanos JJ. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol 172: 2485-2490, 1990.
30. Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res 1: 1001-1008, 2003.
31. Mukherjee S, Hao YH, Orth K. A newly discovered posttranslational modification - the acetylation of serine and threonine residues. Trends Biochem Sci 32: 210-216, 2007. (Pubitemid 46694332)
32. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214, 2006. (Pubitemid 43801146)
33. Nakamura H, Li M, Zarycki J, Jung JU. Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 75: 7572-7582, 2001. (Pubitemid 32738015)
34. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci 95: 7-11, 2004. (Pubitemid 38208400)
35. Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, Mangel WF, Staskawicz B, Dixon JE. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290: 1594-1597, 2000.
36. Patel JC, Rossanese OW, Galan JE. The functional interface between Salmonella and its host cell: opportunities for therapeutic intervention. Trends Pharmacol Sci 26: 564-570, 2005.
37. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505, 1993. (Pubitemid 23335075)
38. Skinn AC, Vergnolle N, Zamuner SR, Wallace JL, Cellars L, Mac- Naughton WK, Sherman PM. Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice. Can J Physiol Pharmacol 84: 1301-1312, 2006. (Pubitemid 46707379)
39. Streckel W, Wolff AC, Prager R, Tietze E, Tschape H. Expression profiles of effector proteins SopB, SopD1, SopE1, and AvrA differ with systemic, enteric, and epidemic strains of Salmonella enterica. Mol Nutr Food Res 48: 496-503, 2004. (Pubitemid 39643692)
40. Sun J, Hobert ME, Duan Y, Rao AS, He TC, Chang EB, Madara JL. Crosstalk between NF-κB and β-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 289: G129-G137, 2005. (Pubitemid 40944231)
41. Sun J, Hobert ME, Rao AS, Neish AS, Madara JL. Bacterial activation of β-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol 287: G220-G227, 2004. (Pubitemid 38802136)
42. Sweet CR, Conlon J, Golenbock DT, Goguen J, Silverman N. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell Microbiol 9: 2700-2715, 2007. (Pubitemid 47500520)
43. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 408: 307-310, 2000.
44. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev 2: 594-604, 2002. (Pubitemid 37328926)
45. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699, 2004.
46. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016-1022, 2009.
47. Yamaguchi H, Woods NT, Piluso LG, Lee HH, Chen J, Bhalla KN, Monteiro A, Liu X, Hung MC, Wang HG. p53 acetylation is crucial for its transcription- independent proapoptotic functions. J Biol Chem 284: 11171-11183, 2009.
48. Ye Z, Petrof EO, Boone D, Claud EC, Sun J. Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol 171: 882-892, 2007.
49. Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med 202: 1327-1332, 2005.